Gelsosomos Franchise Corporation – Trademark Portfolio
Entity Type: 03
Gelsosomos Franchise Corporation has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 1 is successfully registered — a 50% registration rate. The portfolio includes marks such as GP GELSOSOMO'S PIZZERIA. Filings span 3 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in Hobart, IN.
317 N. Shelby Street
Hobart, IN 46342
Showing of trademarks Trademarks
Trademark Classifications
Gelsosomos Franchise Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Gelsosomos Franchise Corporation have?
Gelsosomos Franchise Corporation has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Gelsosomos Franchise Corporation file in?
Gelsosomos Franchise Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 43 (Hotels & Restaurants). Class 35 covers advertising; business management; business administration; office functions.
What are Gelsosomos Franchise Corporation's most well-known trademarks?
Gelsosomos Franchise Corporation's registered trademark portfolio includes well-known marks such as GP GELSOSOMO'S PIZZERIA. These are among 1 currently registered trademark in the portfolio.
What is Gelsosomos Franchise Corporation's trademark registration success rate?
Gelsosomos Franchise Corporation has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.